Medical Equipment

Congestive Heart Failure Treatment Devices Market Forecast Analysis Through 2030 With Insights On Industry Expansion

May 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Congestive Heart Failure Treatment Devices Market Compare Between 2026 And 2030?

The congestive heart failure treatment devices market has experienced strong growth in recent years. It is anticipated to expand from $21.07 billion in 2025 to $22.76 billion in 2026, at a compound annual growth rate (CAGR) of 8.0%. Historically, this growth can be ascribed to the increasing prevalence of congestive heart failure, the rising incidence of cardiovascular diseases, the expanding usage of implantable cardiac devices, the proliferation of specialized cardiac care facilities, and enhanced survival rates for heart failure patients.

The congestive heart failure treatment devices market size is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $30.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected growth is driven by several factors, including an aging population with elevated heart failure risk, a surging demand for minimally invasive cardiac treatments, an intensified focus on early intervention and managing the disease, broader access to advanced heart failure solutions in developing markets, and the increasing uptake of long-term mechanical circulatory support devices. Key developments expected during this period involve a rise in the adoption of sophisticated implantable heart failure devices, more widespread utilization of ventricular assist devices in advanced congestive heart failure cases, an enhanced emphasis on reducing hospital admissions for heart failure, the broadening of device-based therapies for sustained cardiac support, and a heightened need for continuous cardiac monitoring and management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15774&type=smp

Which Growth Factors Are Strengthening The Congestive Heart Failure Treatment Devices Market Landscape?

The increasing occurrence of cardiovascular conditions is anticipated to fuel the expansion of the congestive heart failure treatment devices market in the future. These disorders encompass a range of diseases affecting the heart and blood vessels, including coronary artery disease, high blood pressure, and heart failure, impacting blood circulation and overall cardiac well-being. The growing incidence of cardiovascular disorders is primarily attributed to higher rates of contributing factors such as obesity, inactive lifestyles, unhealthy eating habits, and an aging demographic. Devices for treating congestive heart failure play a vital role in managing cardiovascular conditions by stabilizing heart rhythms and enhancing heart performance, thereby considerably improving patient outcomes. For instance, as reported in October 2024 by the US government agency, the Centers for Disease Control and Prevention, cardiovascular disease was responsible for 919,032 deaths in 2023, representing one in every three fatalities. Coronary heart disease continued to be the most prevalent type of heart condition, and notably, approximately one in six deaths due to cardiovascular diseases happened among individuals younger than 65 years old. Consequently, the increased occurrence of cardiovascular disorders is propelling the expansion of the congestive heart failure (CHF) treatment devices market.

Which Segment-Based Categories Are Covered In The Congestive Heart Failure Treatment Devices Market?

The congestive heart failure treatment devices market covered in this report is segmented –

1) By Product: Cardiac Pacemaker, Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy Devices (CRT), Counter Pulsation Devices, Ventricular Assist Devices (VADs)

2) By Application: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)

3) By End-User: Hospitals And Clinic, Specialized Cardiovascular Disease Treatment Centers, Ambulatory Surgery Centers

Subsegments:

1) By Cardiac Pacemaker: Single Chamber Pacemaker, Dual Chamber Pacemaker, Biventricular Pacemaker

2) By Implantable Cardioverter Defibrillators (ICDs): Traditional ICDs, Subcutaneous ICDs, CRT-D (Cardiac Resynchronization Therapy Defibrillator)

3) By Cardiac Resynchronization Therapy Devices (CRT): CRT-P (Cardiac Resynchronization Therapy Pacemaker), CRT-D (Cardiac Resynchronization Therapy Defibrillator)

4) By Counter Pulsation Devices: Intra-Aortic Balloon Pumps (IABP), External Counterpulsation Devices (ECP)

5) By Ventricular Assist Devices (VADs): Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Biventricular Assist Devices (BiVAD)

Which Trends Are Affecting The Congestive Heart Failure Treatment Devices Market Framework?

Key companies operating in the congestive heart failure treatment devices market are prioritizing the creation of cutting-edge solutions, including the implant-free atrial septostomy system, to boost hemodynamic relief, minimize procedural complexity, and provide less invasive alternatives for heart failure patients. An implant-free atrial septostomy system is a minimally invasive instrument specifically designed to create a controlled opening within the atrial septum without leaving behind a permanent implant, which leads to improved left atrial pressure reduction and better cardiac hemodynamics in individuals with heart failure. For instance, in January 2025, Alleviant Medical Inc., a US-based medical device company, reached crucial FDA milestones for its innovative no-implant interatrial shunt device aimed at treating heart failure. This device offers a minimally invasive solution for heart failure by creating a precise shunt that effectively lowers elevated pressure in the left atrium without requiring a permanent implant. This method helps to reduce complications often linked with implanted devices, ensures durable shunt patency, and improves symptoms, physical activity levels, and the quality of life for patients with chronic heart failure. Its primary goal is to alleviate strain on the heart, reduce symptoms, and present a safer, novel treatment option for patients who have limited choices.

Who Are The Businesses Driving Activity In The Congestive Heart Failure Treatment Devices Market?

Major companies operating in the congestive heart failure treatment devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co KG, LivaNova PLC, Berlin Heart GmbH, Jarvik Heart Inc, ReliantHeart Inc, Abiomed Inc, Lepu Medical Technology Co Ltd, Magenta Medical Ltd, MicroPort Inc, EBR Systems Inc, Syncardia Systems LLC, Oscor Inc, OSYPKA Medical GmbH, Calon Cardio-Technology, CoreWave SA, Zoll Medical Corporation

Access The Complete Congestive Heart Failure Treatment Devices Market Report:

https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-treatment-devices-global-market-report

Which Region Accounts For The Highest Share Of The Congestive Heart Failure Treatment Devices Market?

North America was the largest region in the congestive heart failure treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Congestive Heart Failure Treatment Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15774&type=smp

Browse Through More Reports Similar to the Global Congestive Heart Failure Treatment Devices Market 2026, By The Business Research Company

Heart Defect Closure Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Congestive Heart Failure Treatment Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-treatment-devices-global-market-report

Structural Heart Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795